GLIVEC Side Effects

5797143-7 | Abdominal Pain, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Haematocrit Decreased, Haemoglobin Decreased, Peritonitis, Red Blood Cell Count Decreased, Surgery
on Jun 19, 2008 Male patient from JAPAN , weighting 116.8 lb, was diagnosed with gastrointestinal stromal tumour and was treated with Glivec (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, peritonitis, red blood cell count decreased, surgery (What is surgery?). Glivec dosage: 400 Mg/day. Patient was hospitalized.

5797142-5 | Pneumatosis Intestinalis
Patient was taking Glivec (View Usage). Patient had the following side effects: pneumatosis intestinalis on Jun 23, 2008 from JAPAN Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with acute lymphocytic leukaemia, disseminated intravascular coagulation, hepatic function abnormal and. Glivec dosage: 600 Mg, Qd. During the same period patient was treated with DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ENDOXAN (2100 Mg, Qd) (View Endoxan Review and Endoxan Label ), ONCOVIN (2 Mg, Qd) (View Oncovin Review and Oncovin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), GRAN (150 Ug, Qd) (View Gran Review and Gran Label ), REMINARON (View Reminaron Review and Reminaron Label ), MINOPHAGEN C (View Minophagen C Review and Minophagen C Label ).

5795551-1 | Tendon Rupture
Adverse event was reported on Jun 18, 2008 by a Female patient taking Glivec (View Usage) (Dosage: 400 Mg/day) was diagnosed with chronic myeloid leukaemia, attention deficit/hyperactivity disorder and. Location: UNITED KINGDOM , 70 years of age, After Glivec was administered, patient had the following side effects: tendon rupture. During the same period patient was treated with RITALIN (5 Mg Five Times Per Day) (View Ritalin Review and Ritalin Label ).

5793599-4 | Coombs Test Negative, Diarrhoea, Haemolysis, Muscle Spasms, Neutrophil Count Decreased
on Jun 17, 2008 Male patient from UNITED KINGDOM , 58 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Glivec (View Usage). Patient experienced the following unwanted or unexpected effects: coombs test negative, diarrhoea, haemolysis, muscle spasms, neutrophil count decreased. Glivec dosage: 300 Mg, Unk. During the same period patient was treated with HYDROXYUREA (Unk) (View Hydroxyurea Review and Hydroxyurea Label ), INTERFERON ALFA (Unk) (View Interferon Alfa Review and Interferon Alfa Label ), ALLOPURINOL (Unk) (View Allopurinol Review and Allopurinol Label ), NEUPOGEN (Unk) (View Neupogen Review and Neupogen Label ).


5793524-6 | Oesophageal Perforation
on Jun 25, 2008 Male patient from SPAIN , 64 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Glivec (View Usage). Patient had the following side effects: oesophageal perforation. Glivec dosage: 600 Mg, Qd.

5785992-0 | Myelodysplastic Syndrome, Platelet Count Decreased
Patient was taking Glivec (View Usage). After Glivec was administered, patient had the following side effects: myelodysplastic syndrome, platelet count decreased on Jun 17, 2008 from SRI LANKA Additional patient health information: Male patient , weighting 116.8 lb, was diagnosed with chronic myeloid leukaemia and. Glivec dosage: 400mg. Patient was hospitalized.

5785979-8 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatinine Increased, Cheilitis, Cytolytic Hepatitis, Dermatitis Bullous, Febrile Bone Marrow Aplasia, Gastric Mucosal Lesion, Hypernatraemia
Adverse event was reported on Jun 12, 2008 by a Male patient taking Glivec (View Usage) (Dosage: 600 Mg/day) . Location: FRANCE , weighting 205.0 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, cheilitis, cytolytic hepatitis, dermatitis bullous, febrile bone marrow aplasia, gastric mucosal lesion, hypernatraemia. During the same period patient was treated with METHOTREXATE (NGX) (Unk) (View Methotrexate (ngx) Review and Methotrexate (ngx) Label ), VINCRISTINE (NGX) (Unk) (View Vincristine (ngx) Review and Vincristine (ngx) Label ), ENDOXAN (Unk) (View Endoxan Review and Endoxan Label ). Patient was hospitalized.

5780253-8 | Acute Lymphocytic Leukaemia, Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Haematocrit Decreased, Haemoglobin Decreased, Monocyte Count Increased
on Jun 12, 2008 Male patient from JAPAN , weighting 163.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Glivec (View Usage). Patient had the following side effects: acute lymphocytic leukaemia, alanine aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, haematocrit decreased, haemoglobin decreased, monocyte count increased. Glivec dosage: 400 Mg/ Day. During the same period patient was treated with ONCOVIN (2 Mg, Unk) (View Oncovin Review and Oncovin Label ), PREDONINE (100 Mg, Unk) (View Predonine Review and Predonine Label ). Patient was hospitalized.

5777365-1 | Disease Progression, Pain, Sarcoma
on Jun 11, 2008 Female patient from BRAZIL , 57 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Glivec (View Usage). After Glivec was administered, patient had the following side effects: disease progression, pain (What is pain?), sarcoma. Glivec dosage: 400 Mg, Qd. Patient was hospitalized.

5777361-4 | Bone Pain, Osteoporosis
Patient was taking Glivec (View Usage). Patient experienced the following unwanted or unexpected effects: bone pain, osteoporosis (What is osteoporosis?) on Jun 12, 2008 from AUSTRIA Additional patient health information: Male patient , 35 years of age, was diagnosed with chronic myeloid leukaemia and. Glivec dosage: Unk.

5777339-0 | Ankle Fracture
Adverse event was reported on Jun 10, 2008 by a Male patient taking Glivec (View Usage) (Dosage: 400 Mg Per Day) was diagnosed with chronic myeloid leukaemia and. Location: , 74 years of age, Patient had the following side effects: ankle fracture. During the same period patient was treated with HYDROXYUREA (Unk) (View Hydroxyurea Review and Hydroxyurea Label ). Patient was hospitalized.

5777325-0 | Erythromelalgia
on Jun 09, 2008 Female patient from , 45 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Glivec (View Usage). After Glivec was administered, patient had the following side effects: erythromelalgia. Glivec dosage: 400 Mg Daily.

5776426-0 | Altered State Of Consciousness, Basilar Artery Stenosis, Blood Creatinine Increased, C-reactive Protein Increased, Cerebral Artery Embolism, Computerised Tomogram Abnormal, Csf Cell Count Increased, Diarrhoea, Disorientation
on Jun 11, 2008 Male patient from JAPAN , 58 years of age, was diagnosed with chronic eosinophilic leukaemia and was treated with Glivec (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, basilar artery stenosis, blood creatinine increased, c-reactive protein increased, cerebral artery embolism, computerised tomogram abnormal, csf cell count increased, diarrhoea, disorientation. Glivec dosage: 100 Mg/day. Patient was hospitalized.

5775497-5 | Acute Myocardial Infarction, Decreased Appetite, Fall, Mouth Ulceration, Pelvic Fracture
Patient was taking Glivec (View Usage). Patient had the following side effects: acute myocardial infarction, decreased appetite, fall (What is fall?), mouth ulceration, pelvic fracture on May 15, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 68 years of age, was diagnosed with chronic myeloid leukaemia and. Glivec dosage: 600 Mg, Unk. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

5775452-5 | Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Disseminated Intravascular Coagulation, Haematocrit Decreased, Haemoglobin Decreased, Platelet Count Decreased, Red Blood Cell Count Decreased, Tumour Lysis Syndrome, White Blood Cell Count Decreased
Adverse event was reported on Jun 09, 2008 by a Male patient taking Glivec (View Usage) (Dosage: 400 Mg, Qd) was diagnosed with acute lymphocytic leukaemia and. Location: , weighting 143.3 lb, After Glivec was administered, patient had the following side effects: blood bilirubin increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, tumour lysis syndrome, white blood cell count decreased. During the same period patient was treated with FOY (2 Df/day) (View Foy Review and Foy Label ).

5774329-9 | Finger Hypoplasia
on Jun 04, 2008 Female patient from UNITED KINGDOM , weighting 6.31 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Glivec (View Usage). Patient experienced the following unwanted or unexpected effects: finger hypoplasia. Glivec dosage: Maternal Dose: 400 Mg Qd. During the same period patient was treated with INTRON A (Unk) (View Intron A Review and Intron A Label ), NEUPOGEN (Maternal Dose: 40 Miu Qw) (View Neupogen Review and Neupogen Label ), IMMUNOGLOBULINS (Maternal Dose: 500 Iu) (View Immunoglobulins Review and Immunoglobulins Label ).

5506588-1 | Muscle Spasms, Nervousness, Neuropathy Peripheral, Paraesthesia, Polyneuropathy, Restlessness
on Oct 31, 2007 Male patient from GERMANY , 82 years of age, weighting 149.9 lb, was diagnosed with chronic myeloid leukaemia, osteoporosis (What is osteoporosis?), hypertension, asthma (What is asthma?) and was treated with Glivec (View Usage). Patient had the following side effects: muscle spasms, nervousness, neuropathy peripheral, paraesthesia, polyneuropathy, restlessness. Glivec dosage: 400 Mg/day. During the same period patient was treated with TILIDINE (View Tilidine Review and Tilidine Label ), DIOVAN (View Diovan Review and Diovan Label ), SULTANOL (View Sultanol Review and Sultanol Label ), ATROVENT (View Atrovent Review and Atrovent Label ), BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), THYRONAJOD (View Thyronajod Review and Thyronajod Label ).

5506182-2 | Breast Cancer, Breast Microcalcification, Surgery
Patient was taking Glivec (View Usage). After Glivec was administered, patient had the following side effects: breast cancer (What is breast cancer?), breast microcalcification, surgery (What is surgery?) on Oct 29, 2007 from FRANCE Additional patient health information: Female patient , 68 years of age, was diagnosed with chronic myeloid leukaemia and. Glivec dosage: 400 Mg Daily. During the same period patient was treated with AMN107 (400 Mg Daily) (View Amn107 Review and Amn107 Label ), SPRYCEL (140 Mg Daily) (View Sprycel Review and Sprycel Label ).

5506154-8 | Pleural Effusion, Pneumonia Aspiration
Adverse event was reported on Oct 26, 2007 by a Female patient taking Glivec (View Usage) (Dosage: 600 Mg/d) was diagnosed with acute lymphocytic leukaemia and. Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: pleural effusion, pneumonia aspiration. During the same period patient was treated with VINCRISTINE SULFATE (1.9 Mg/d) (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISOLONE (60 Mg/d) (View Prednisolone Review and Prednisolone Label ).

5505944-5 | Albuminuria, Hypoalbuminaemia, Nephropathy, Oedema, White Blood Cell Count Increased
on Oct 31, 2007 Male patient from TURKEY , 32 years of age, weighting 138.9 lb, was diagnosed with chronic myeloid leukaemia and was treated with Glivec (View Usage). Patient had the following side effects: albuminuria, hypoalbuminaemia, nephropathy, oedema, white blood cell count increased. Glivec dosage: 400 Mg, Qd. Patient was hospitalized.

5505838-5 | Amnesia, Arthralgia, Cluster Headache, Conjunctival Haemorrhage, Eye Swelling, Faecal Incontinence, Gastric Disorder, Muscle Spasms, Oedema Peripheral
on Oct 25, 2007 Female patient from UNITED KINGDOM , 66 years of age, was treated with Glivec (View Usage). After Glivec was administered, patient had the following side effects: amnesia, arthralgia, cluster headache, conjunctival haemorrhage, eye swelling, faecal incontinence, gastric disorder, muscle spasms, oedema peripheral. Glivec dosage: 400mg. During the same period patient was treated with INTERFERON (5mu) (View Interferon Review and Interferon Label ).

5505242-X | Conjunctivitis, Enanthema, Erythema, Erythema Multiforme, Feeling Hot, Headache, Neutropenia, Oculomucocutaneous Syndrome, Pruritus
Patient was taking Glivec (View Usage). Patient experienced the following unwanted or unexpected effects: conjunctivitis, enanthema, erythema, erythema multiforme, feeling hot, headache (What is headache?), neutropenia, oculomucocutaneous syndrome, pruritus on Oct 24, 2007 from JAPAN Additional patient health information: Female patient , 56 years of age, weighting 114.6 lb, was diagnosed with chronic myeloid leukaemia and. Glivec dosage: 300 Mg/day. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

5503654-1 | Pneumatosis Intestinalis
Adverse event was reported on Oct 24, 2007 by a Male patient taking Glivec (View Usage) (Dosage: 600 Mg/d) was diagnosed with acute lymphocytic leukaemia, disseminated intravascular coagulation, hepatic function abnormal and. Location: JAPAN , 18 years of age, weighting 132.3 lb, Patient had the following side effects: pneumatosis intestinalis. During the same period patient was treated with DAUNORUBICIN HCL (100 Mg/d) (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), PREDONINE (100 Mg/d) (View Predonine Review and Predonine Label ), ENDOXAN (2100 Mg/d) (View Endoxan Review and Endoxan Label ), ONCOVIN (2 Mg/d) (View Oncovin Review and Oncovin Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), GRAN (150 Ug/d) (View Gran Review and Gran Label ), REMINARON (150 Mg/d) (View Reminaron Review and Reminaron Label ), MINOPHAGEN C (60 Ml/d) (View Minophagen C Review and Minophagen C Label ).

4693087-2 | Diarrhoea, Pyrexia, Sepsis
on May 28, 2005 Male patient from , 31 years of age, weighting 105.8 lb, was diagnosed with chronic myeloid leukaemia and was treated with Glivec (View Usage). After Glivec was administered, patient had the following side effects: diarrhoea, pyrexia, sepsis (What is sepsis?). Glivec dosage: 600 Mg, Qd. Patient was hospitalized.

4570399-4 | Chest Pain, Chronic Obstructive Pulmonary Disease, Cough, Difficulty In Walking, Dyspnoea, Infection, Productive Cough, Wheezing
on Oct 01, 2004 Female patient from , 55 years of age, weighting 99.21 lb, was diagnosed with chronic myeloid leukaemia and was treated with Glivec (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), chronic obstructive pulmonary disease, cough, difficulty in walking, dyspnoea, infection (What is infection?), productive cough, wheezing. Glivec dosage: 400 Mg, Qd. Patient was hospitalized.

4569365-4 | Hyperammonaemia, Malaise, Malignant Neoplasm Progression, Oedema Peripheral, Pleural Effusion, Transaminases Increased, Vomiting, White Blood Cell Count Decreased
Patient was taking Glivec (View Usage). Patient had the following side effects: hyperammonaemia, malaise, malignant neoplasm progression, oedema peripheral, pleural effusion, transaminases increased, vomiting, white blood cell count decreased on Feb 04, 2004 from Additional patient health information: Female patient , 57 years of age, weighting 105.8 lb, was diagnosed with gastrointestinal stromal tumour and. Glivec dosage: 400 Mg, Qd.